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Foxp3-expressing regulatory T (Treg) cells suppress pathology mediated by immune responses against self
and foreign antigens and commensal microorganisms. Sustained expression of the transcription factor
Foxp3, a key distinguishing feature of Treg cells, is required for their differentiation and suppressor function.
In addition, Foxp3 expression prevents deviation of Treg cells into effector T cell lineages and confers depen-
dence of Treg cell survival and expansion on growth factors, foremost interleukin-2, provided by activated
effector T cells. In this reviewwe discuss Treg cell differentiation andmaintenance with a particular emphasis
on molecular regulation of Foxp3 expression, arguably a key to mechanistic understanding of biology of
regulatory T cells.One century ago Paul Ehrlich proposed that the immune system
is programmed to avoid the generation of autoreactive immune
responses and termed this aversion to autoreactivity ‘‘horror
autotoxicus’’ (Ehrlich, 1906). Ehrlich’s observations that goats
could make antibodies against the blood components of other
goats, but not against their own blood, represented the first
evidence of immunological self-tolerance and led to his predic-
tion that ‘‘either the disappearance of receptors or the presence
of autoantitoxins is foremost among [immune] contrivances’’ that
mediate self-tolerance. It is currently well accepted that immu-
nological tolerance is mediated by two categories of mecha-
nisms—recessive and dominant. Recessive tolerance refers to
cell-intrinsic mechanisms that include elimination of self-reactive
thymocytes or chronically stimulated peripheral T cell clones by
apoptosis or their inactivation resulting from anergy induction.
Dominant tolerance is mediated by a specialized subset of
immune cells acting in trans to restrain pathogenic immune
responses. Although several lymphoid cell subsets exhibit
suppressive or immunomodulatory properties, Foxp3-express-
ing Treg cells represent the only currently known population of
lymphocytes acting as dedicated mediators of dominant toler-
ance, whose suppressor function is vital for the maintenance
of immune homeostasis. Treg cells suppress immune responses
through numerous mechanisms including the production of anti-
inflammatory cytokines, direct cell-cell contact, and by modu-
lating the activation state and function of antigen presenting
cells (reviewed by Shevach [2009] in this issue of Immunity).
It is becoming increasingly apparent that in addition to
restraining autoimmunity, Treg cell suppressor function promi-
nently features in regulation of other forms of immune-mediated,
and likely, nonimmune, inflammation, and affects immune res-
ponses to infection and tumor growth.
Foxp3 and Regulatory T Cell Differentiation
Initial insights that revealed the existence of a thymus-derived
subset of cells capable of mediating immune tolerance through
their suppression of other cells came from neonatal thymectomy
(nTx) experiments performed by Nishizuka and Sakaguchi and616 Immunity 30, May 22, 2009 ª2009 Elsevier Inc.their colleagues and in studies of tolerance in chicken-quail
chimeras performed by Le Dourain and her colleagues (Ohki
et al., 1987). In mouse thymectomy studies, nTx between 2 and
4 days of life resulted in T cell-mediated lesions, which could be
alleviated through the transfer of thymocytes or splenocytes
from adult euthymic mice (Asano et al., 1996; Bonomo et al.,
1995; Nishizuka and Sakakura, 1969; Sakaguchi et al., 1982).
Thus, a population of cells generated in the mouse thymus after
3 days of life mediates immune tolerance in a dominant, cell-
extrinsic manner. In a landmark 1995 paper, Sakaguchi and
colleagues described a population of IL-2 receptor a chain
(CD25)-expressing CD4+ T cells that were capable of suppress-
ing immune responses in a variety of experimental models
(Sakaguchi et al., 1995). Recent progress in understanding
Treg cell biology came with the discovery of the X chromo-
some-encoded gene Foxp3 during efforts to identify the genetic
basis for the autoimmune disorder in human patients suffering
from IPEX (immune dysregulation, polyendocrinopathy, enterop-
athy, X-linked) syndrome and in the spontaneous mouse mutant
scurfy (Bennett et al., 2001; Brunkow et al., 2001; Chatila et al.,
2000; Wildin et al., 2001). Mice and humans harboring a loss-
of-function mutation in the Foxp3 gene are affected by fatal early
onset lymphoproliferative immune-mediated disease affecting
a variety of organs and tissues. Subsequent studies revealed
stable expression of high amounts of Foxp3 restricted to Treg
cells and its requirement for Treg cell differentiation (Fontenot
et al., 2003, 2005c; Hori et al., 2003; Khattri et al., 2003; Wan
and Flavell, 2007) and for their suppressor function, proliferative
potential, and metabolic fitness (Gavin et al., 2007; Lin et al.,
2007). Furthermore, sustained Foxp3 expression in mature
Treg cells is necessary for maintenance of the Treg cell pheno-
type and suppressor function; loss of Foxp3 or its diminished
expression in Treg cells leads to acquisition of effector T cell
properties including production of immune response-promoting
cytokines such as IL-2, IL-4, IL-17, and IFN-g (Wan and Flavell,
2007; Williams and Rudensky, 2007). Together, these studies




Figure 1. Differentiation of Thymic and Induced Treg Cells
(A) Most Foxp3+ thymic Treg (tTreg) cells differentiate from Foxp3-negative CD4+ SP thymocytes. The process of tTreg cell differentiation as defined by induction
of Foxp3 requires: (1) increased strength of T cell receptor (TCR) stimulation by self-peptide-MHC complexes presented by thymic epithelial cells (TECs) or
dendritic cells (DCs), (2) CD28 signaling induced by CD80 and CD86 ligand expressed on antigen-presenting cells, and (3) high-affinity IL-2 receptor and other
gc cytokine receptor signaling. Treg cell homeostasis is dependent on exocrine IL-2 produced by effector T cells.
(B) Foxp3+ Treg cells can also be induced from peripheral naive CD4+ T cells (iTreg). Conditions favoring the peripheral induction of Foxp3 include chronic low-
dose antigen stimulation under tolerizing conditions. iTreg cells are likely prominent in the gut-associated lymphoid tissue where chronic exposure to food,
commensal, or environmental antigens probably facilitates their generation. Suboptimal costimulation is critical for differentiation of iTreg cells with a particularly
important role for the immunomodulatory cytokine TGF-b. Additionally, IL-2 and the vitamin A metabolite retinoic acid (RA) facilitate induction of Foxp3 in periph-
eral Foxp3 CD4 T cells. CD103+ DCs, which produce RA and TGF-b, are potent inducers of Foxp3 expression in activated T cells. These dendritic cells are
present in high numbers in the gut where they probably limit immune inflammation through the generation of iTreg cells.Thymic and Peripheral Differentiation of Treg Cells
Given the central role of Foxp3 in establishing and maintaining
the Treg cell transcriptional program, elucidation of the cell-
extrinsic and -intrinsic cues that influence Foxp3 expression
will facilitate an understanding of the differentiation, mainte-
nance, and function of Treg cells.
Foxp3 induction leading to Treg cell differentiation occurs rela-
tively late during thymic differentiation. In addition, peripheral
naive CD4+ T cells are also capable of Foxp3 upregulation during
differentiation into so-called induced Treg cells or iTreg cells
(Figure 1; reviewed in this issue of Immunity by Curotto de
Lafaille and Lafaille [2009]). Presently, it is not clear whether these
two modes of Treg cell differentiation serve different biological
needs or have partially or fully redundant functions and whether
mechanistic requirements for Treg cell generation in the thymus
and in the periphery are distinct. Furthermore, the overall contri-
bution of thymically generated Treg cells (tTreg) and peripherally
generated iTreg cells to the overall pool of Treg cells in secondary
lymphoid organs and nonlymphoid tissues under basal condi-
tions and in the course of immune challenge or tumor growth
remain largely unknown. Below we will discuss these issues in
the context of recent work related to regulation of Foxp3 gene
expression in the thymus and periphery.Role of TCR Signals in Treg Cell Differentiation
T cell receptor (TCR) signals of distinct strength and duration
have been proposed to guide CD4 versus CD8 T cell fate deci-
sion during thymic differentiation (Germain, 2002; Singer et al.,
2008). Furthermore, distinct strong TCR signaling facilitates
generation of ‘‘specialized’’ populations of T cells such as CD1d-
restricted NKT cells, MR1-restricted MAIT (mucosal associated
invariant T cells) expressing semi-invariant TCRs, CD8aa T cells,
and H-M3-restricted CD8+ T cells expressing diverse TCR.
Considering that TCR-ligand interactions are central to T cell
lineage decision making, an essential role and requirement for
particular TCR signaling in Foxp3 induction and Treg cell lineage
commitment comes as no surprise. Early observations of high
expression of molecules known to be upregulated in T cells
upon acute or chronic TCR signaling, i.e., CD25, CD5, and
CTLA-4, strongly supported the idea that Treg cells are exposed
to TCR signals of increased strength. CD5 expression in thymo-
cytes and peripheral T cells is proportional to the strength of TCR
signals these cells are exposed to, and thereby, CD5 acts as
a rheostat attenuating TCR signaling in a tunable manner through
recruitment of the tyrosine phosphatase SHP-1 to the CD5 cyto-
plasmic tail (Azzam et al., 2001; Wong et al., 2001). Indeed, CD5-
or SHP-1-deficient mice have increased frequencies of tTregImmunity 30, May 22, 2009 ª2009 Elsevier Inc. 617
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2005).
The idea of an essential role of TCR engagement in Foxp3
induction during thymic differentiation of Treg cells gained direct
experimental support from earlier observations of endogenous
TCR rearrangement-dependent Treg cell generation in mice
expressing a transgenic TCR (Olivares-Villagomez et al., 1998).
Next, it was found that, in the absence of endogenous TCR rear-
rangement, Treg cells expressing a transgene-encoded TCR are
generated only when a cognate ligand for the receptor, encoded
by another transgene, was coexpressed (Apostolou et al., 2002;
Jordan et al., 2001; Kawahata et al., 2002; Walker et al., 2003).
Pronounced negative selection accompanying generation of
tTreg cells in these studies (Apostolou et al., 2002; Kawahata
et al., 2002; Walker et al., 2003) led to a notion of selective
survival of thymic self-reactive Treg cell precursors expressing
Foxp3 as opposed to instructive TCR signals driving Foxp3
expression (van Santen et al., 2004). Consistent with this idea
is increased Foxp3-dependent expression of prosurvival mole-
cules and known attenuators of TCR signaling such as CTLA-4.
Nevertheless, as we discuss below, recent studies, although not
discounting superior survival of Foxp3+ thymocytes, provide
further support to an instructive role for TCR signaling in Treg
cell lineage commitment in the thymus.
In addition to somewhat contrived experimental models of Treg
cell differentiation in TCRtransgenic mice, a direct sequence anal-
ysis of the TCR repertoires displayed by Treg versus non-Treg
cells bearing a fixed transgene-encoded TCR-b chain showed
that TCR-a sequences in Treg cells were diverse and only partially
overlapping with non-Treg cells (Hsieh et al., 2004; Pacholczyk
et al., 2006; Pacholczyk and Kern, 2008; Wong et al., 2007b).
Retroviral transfer of Treg cell or naive CD4+ T cell TCRa libraries
into RAG/ TCR transgenic T cells followed by the analysis of
reactivity of Treg cell- versus non-Treg cell-derived TCR showed
that Treg cell TCR exhibit increased self-reactivity. This is based
on their ability to confer to T cells the capacity for robust expan-
sion and induction of autoimmune pathology upon transfer into
lymphopenic recipient mice. Nevertheless, these TCR transgenic
T cells transduced with Treg cell TCR are able to mount only weak
in vitro responses to syngeneic APC in comparison to the
responses of these cells to the ‘‘foreign’’ ligand recognized by
the transgenic TCR (Hsieh et al., 2004). Thus, it seems likely that
although increased, the affinity of Treg cell TCR for self-antigens
is well below the range of conventional T cell receptors recog-
nizing foreign antigen in a typical immune response. These data
support the idea that Treg cell selection is facilitated by TCR
with affinities for self peptide-ligands falling within a range
between positive selection of conventional CD4+ T cells and
negative selection of high-affinity self-reactive T cells (Figure 1).
This notion is supported by observations that the presence or
absence of theFoxp3 gene does not affect efficiency or sensitivity
of negative selection of thymocytes by a high-affinity TCR ligand
(Chen et al., 2005; Hsieh et al., 2006) and that activated T cells
in Foxp3-deficient mice displayed TCR utilized by Treg cells in
Foxp3-sufficient mice (Hsieh et al., 2006). Thus, in the absence
of Foxp3, T cell precursors with self-reactive TCR supporting
Foxp3 induction and differentiation of Treg cells are not deleted,
and instead, upon maturation, become activated and contribute
to pathology in Foxp3-deficient animals.618 Immunity 30, May 22, 2009 ª2009 Elsevier Inc.Understanding of a role of TCR in Treg cell differentiation and
function could have benefited from analysis of transgenic mice
expressing a single monoclonal Treg cell TCR originating from
Treg cells present in normal mice. An unexpected problem
in these studies has been that in the absence of endogenous
TCR rearrangements on a RAG-deficient background, such
transgenic Treg cell-derived TCR support differentiation of
a very small number, if any, of Foxp3+ Treg cells (C.S. Hsieh,
J. Marie, J.D. Fontenot, and A.R., unpublished observations).
However, very recent experiments by the Hsieh group demon-
strated an efficient generation of Foxp3+ thymocytes expressing
a single Treg cell-derived transgenic TCR when the number of
precursor cells was dramatically reduced. Although mecha-
nism(s) underlying this phenomenon remains uncertain, we
suggest that it is probably the result of a very narrow window of
affinity of TCR-ligand interactions between negative selection
and positive selection of Foxp3 cells that satisfy the require-
ments for Foxp3 induction. Overall, these data suggest that
an unprecedented intraclonal competition limits induction of
Foxp3 in thymic precursors expressing TCR of identical speci-
ficity ensuring a very broad Treg cell TCR specificity repertoire
(Bautista et al., 2009).
In addition to TCR signals, CD28 costimulatory signals have an
essential cell-intrinsic role in the differentiation of tTreg cells as
illustrated by marked decreases in frequencies of tTreg cells
in CD28-deficient and CD80-CD86-deficient mice (Salomon
et al., 2000; Tai et al., 2005). Additionally, the lck-binding domain
of the CD28 cytoplasmic tail is critical for the induction of Foxp3
(Tai et al., 2005), thereby suggesting a role for coordinated TCR-
CD28 signaling in thymic differentiation of Treg cells (Figure 1).
Several transcription factors downstream of the TCR and
CD28, including NFAT, NF-kB, and AP-1, have been implicated
in Treg cell differentiation. In agreement with their proposed role
in upregulation of Foxp3 expression, NFAT and AP1 bind to the
Foxp3 promoter (Mantel et al., 2006). In addition, CREB-ATF-1
was shown to bind an intronic regulatory region at the Foxp3
locus (Foxp3 conserved noncoding sequence 2, Foxp3-CNS2)
and enhance expression of a luciferase reporter driven by a
Foxp3 promoter in a transient transfection assay (Kim and Leo-
nard, 2007). Also, studies of mice with targeted ablation of genes
encoding components of a TCR-dependent NF-kB signaling
pathway, PKC-q, Bcl10, CARMA1, and IkB kinase 2, showed
significant impairment in tTreg cell differentiation (Gupta et al.,
2008; Medoff et al., 2009; Schmidt-Supprian et al., 2004).
Furthermore, a recent study of a CARMA1 (caspase recruitment
domain 11) mutation generated in an ENU-mutagenesis screen
demonstrated a complete cell-intrinsic block in Treg cell differ-
entiation in the thymus (Barnes et al., 2009). Importantly, Allegre
and colleagues found that provision of survival signals to
CARMA1-deficient T cell precursors through forced expression
of Bcl2 or a constitutively active form of STAT5 (STAT5-CA) fail
to rescue the defect in thymic Foxp3 induction and tTreg cell
differentiation (Molinero et al., 2009). These observations
strongly support an instructive role for TCR signaling in Treg
cell differentiation (Figure 2).
Although thesestudiesmade the importance of NF-kB signaling
in thymic Treg cell differentiation clear, little is known about the
specific NF-kB family members that are required for Treg cell
differentiation. One recent study indicated that frequencies of
Immunity
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T cell receptor (TCR) and CD28 costimulatory signals are important for induction of Foxp3. Downstream of the TCR-CD28 signal, the NF-kB pathway via PDK1,
PKC-q, the BCL-10, MALT1, CARMA1 complex, and IKK is critical for Foxp3 expression in the thymus, whereas CREB, NFAT, and AP1 have been demonstrated
to bind to regulatory DNA elements at the Foxp3 locus. In contrast to thymic differentiation of Treg cells, weaker TCR-CD28 signals appear to favor peripheral
induction of Foxp3. TCR and CD28 signaling together with IL-2 and TGF-b are likely important for the survival and proliferation of Treg cell precursors in addition to
their putative direct effects on Foxp3 expression. STAT5, activated downstream of the IL-2 receptor, binds to the promoter and an intronic regulatory DNA
element within the Foxp3 locus and may have a role in transcriptional regulation of Foxp3. TGF-b-dependent synergistic binding of NFAT and Smad to conserved
noncoding sequence 1 (Foxp3-CNS1) is important for the peripheral induction of Foxp3. Transcription of the Foxp3 gene is likely dependent on other regulatory
DNA elements in addition to the Foxp3 promoter. Foxp3-CNS2 may function in the stable maintenance of Foxp3 expression. This function of CNS2 is dependent
on demethylation of the CpG island located at this region, indicating that methyl-sensitive transcription factor binding probably mediates stable expression of
Foxp3. Some in vitro generated iTreg cells and activated human CD4 T cells only transiently express Foxp3, perhaps because of a heavily methylated state
at CNS2. Permissive chromatin modifications such as methylation of histone 3 at lysine residue 4 (H3K4me) and acetylation of histone 3 (H3Ac) at the promoter
and CNS1 associate with active transcription of Foxp3, whereas CNS2 chromatin is only found in a permissive state, with demethylated CpG motifs, in mature
Treg cells that stably express Foxp3. Receptors and extracellular signals are represented in yellow boxes and signaling intermediates and transcription factors
in green. Regulatory DNA elements are highlighted in yellow. The grey box with green dotted outlines contains factors thought to be specifically important for
peripheral Foxp3 induction.Immunity 30, May 22, 2009 ª2009 Elsevier Inc. 619Foxp3-positive thymocytes were reduced in mice bearing a muta-
tion in the p105 gene that results in an inability of IKK (IkB kinase) to
phosphorylate cleaved p50 (Sriskantharajah et al., 2009). In addi-
tion, it is still unclear how NF-kB family members act to mediate
differentiation of Foxp3+ Treg cells, what NF-kB dimer(s) is critical
in this process, and, if NF-kB family members directly regulate the
Foxp3 gene, what sites at the Foxp3 locus they bind to and how
they affect Foxp3 expression.
Role of Cytokines in Thymic Differentiation of Treg Cells
Similar to aforementioned study of TCR utilization by peripheral
Treg cells, sequence analysis of TCR repertoires displayed by
thymic precursors of Treg versus non-Treg cells revealed partial
overlap and bias of thymic Treg cell TCR toward self-recognition
(Hsieh et al., 2006). Thus, the same TCR with an increased reac-
tivity for self can be expressed by a Treg and non-Treg cell, sug-
gesting that TCR signals alone are not sufficient to drive Foxp3
upregulation and Treg cell lineage commitment. Likewise, only
some thymocytes in TCR transgenic RAG-deficient mice differ-
entiate into Treg cells when confronted with the cognate ligand,whereas the rest become anergic ‘‘non-Treg’’ cells (Apostolou
et al., 2002; Jordan et al., 2001). Additional evidence pointing
to a requirement for a second signal was provided by observa-
tion of a delay in generation of Foxp3+ thymocytes in neonatal
mice whereas their CD25+ Foxp3 precursors (see below) are
readily detectable in the thymus immediately after birth (Burchill
et al., 2008; Fontenot et al., 2005a; Lio and Hsieh, 2008).
Because the early wave of thymocytes is not known to be devoid
of, but rather is enriched in, self-reactive TCR because of lack of
TdT expression (Gavin and Bevan, 1995), this delay is most likely
due to the paucity of an additional factor(s) required for Treg cell
differentiation (Figures 1 and 2).
An essential second signal for Treg cell differentiation is
afforded by IL-2 and to a lesser degree two other common
gamma-chain (gc) cytokines, IL-7 and IL-15. Mice lacking IL-2
or IL-2Ra chain exhibit an approximately 50% decrease in
proportion and numbers of Foxp3+ thymocytes, whereas IL-15
or IL-7 deficiency does not affect generation of Foxp3+ cells. In
contrast,mice lackinggc are completely devoid of Foxp3+ thymo-
cytes and peripheral Foxp3+ T cells (Fontenot et al., 2005b) and so
Immunity
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(Burchill et al., 2007a; Malek, 2008; Vang et al., 2008).
Building on the aforementioned observation of CD25+Foxp3
cells preceding generation of CD25+Foxp3+CD4+ single-positive
(SP) thymocytes in the neonatal thymus and on a prominent role
for IL-2 and increased strength TCR signaling in Treg cell differ-
entiation, Lio and Hsieh proposed a two-step model of thymic
Treg cell differentiation based on their intrathymic cell transfer
studies (Burchill et al., 2008; Lio and Hsieh, 2008). According
to this model, an increased TCR signal results in the upregula-
tion of CD25, increasing the responsiveness of tTreg precursor
cells to consequent IL-2 signals that result in induction of
Foxp3 (Burchill et al., 2008; Lio and Hsieh, 2008). STAT5, acti-
vated downstream of IL-2R and other common g-chain cytokine
receptors, represents a likely candidate transcription factor for
direct regulation of Foxp3 expression (Burchill et al., 2008).
Indeed, STAT5 was shown to bind the Foxp3 promoter and
Foxp3-CNS2 element. Furthermore, induced ablation of a condi-
tional Stat5 allele in DP thymocytes results in a drastic reduction
in Foxp3+ CD4SP thymocytes, with the remaining Foxp3+
thymocytes originating from cells that escape STAT5 deletion
(Burchill et al., 2007b; Yao et al., 2007). Additionally, expression
of a constitutively active STAT5 results in expansion of tTreg
cells and can rescue tTreg cell numbers in the absence of IL-2
(Burchill et al., 2003, 2008).
Nevertheless, the molecular mechanisms by which IL-2 facili-
tates Treg cell differentiation are not clear. Although there is an
important function for the IL-2 receptor-STAT5 axis in the differ-
entiation of Treg cells, it remains unclear whether STAT5 directly
drives Foxp3 transcription, induces changes in the chromatin
characteristics at the Foxp3 locus, or promotes survival or
expansion of Treg cells or their precursors. If STAT5 serves an
essential nonredundant role in driving expression of Foxp3,
rather than facilitating the survival of Foxp3-expressing cells,
then forced expression of a prosurvival molecule like Bcl2 in
STAT5-deficient cells should not rescue Treg cell deficiency.
However, expression of a Bcl-2 transgene rescued the differen-
tiation of STAT5-deficient Treg cells, suggesting that Foxp3 can
be induced in the absence of STAT5 in developing thymocytes
(S. Malin and M. Busslinger, personal communication). Addition-
ally, STAT5 is not required for maintenance of Foxp3 expression
in Treg cells, as shown by the fact that conditional ablation of
STAT5 in Treg cells did not result in markedly lower of Foxp3
expression (Y. Zheng and A.R., unpublished observations). Simi-
larly, Foxp3 expression was still maintained in Treg cells upon
conditional deletion of calcineurin B1 and impaired NFAT activa-
tion (J. Kim, G. Crabtree, and A.R., unpublished observations).
In addition to TCR and gc cytokine receptors, a recent study
by Chen and colleagues suggested that an early wave of
Foxp3+ thymocyte generation is dependent upon TGF-b receptor
(TGF-bR) signaling known to drive Foxp3 expression in periph-
eral naive Foxp3 T cells upon their activation (see below). In
support of this notion, ablation of the TGF-bRI subunit in DP
thymocytes resulted in a profound but transient impairment in
generation of Foxp3+ Treg cells during the first week of life fol-
lowed by the recovery of Foxp3 thymocyte numbers to those
observed in wild-type mice (Liu et al., 2008). Earlier reports
also failed to find a defect in tTreg cell generation in week-old
mice lacking of TGF-b1 or subjected to TGF-bRII ablation in620 Immunity 30, May 22, 2009 ª2009 Elsevier Inc.DP thymocytes (Li et al., 2006; Marie et al., 2005, 2006). It was
proposed that in resemblance of peripheral generation of
Foxp3+ iTreg cells discussed in detail below, TGF-b-induced
Smad-mediated activation of the Foxp3 locus through interac-
tion with a conserved Smad-NFAT response element (Foxp3
conserved noncoding sequence 1 [Foxp3-CNS1]) in thymocytes
is essential for tTreg cell generation (Tone et al., 2008). The
recovery of tTreg cells was explained by compensation of
TGF-b signaling deficiency afforded by increasing amounts of
IL-2 (Liu et al., 2008). However, in addition to a proposed role
for Smad-mediated induction of Foxp3 expression, there are
several alternative explanations for the observed effect of TGF-b
on tTreg cell generation including the survival of tTreg cells or
their precursors when a relatively small cohort of thymic precur-
sors reaches maturity in the neonatal thymus. Thus, elucidation
of the transcription factors that bind to the Foxp3 gene and are
required for transcriptional activation and maintenance of
Foxp3 expression remains a challenge for the field.
Requirements for Peripheral Differentiation of Treg
Cells
Initial in vitro and in vivo studies showed that induction of Foxp3
expression in peripheral naive T cells is facilitated by a suboptimal
TCR signal or by a combination of strong TCR signal with high
amounts of TGF-b (Chen et al., 2003; Kretschmer et al., 2005;
Selvaraj and Geiger, 2007; Zheng et al., 2004). However, these
findings do not necessarily indicate that any chronic exposure
of a peripheral T cell to a cognate self or foreign antigen can
lead to generation of Treg cells in the periphery nor do they
suggest that iTreg cells make up a large proportion of the periph-
eral Treg cell population in the secondary lymphoid organs. In
opposition to the latter idea, substantial overlaps were observed
between TCR repertoires displayed by thymic and peripheral
Foxp3+ cells and by thymic and peripheral Foxp3 CD4+ T cells,
respectively. Complementing these data, a comparison of TCR
utilization of thymic Foxp3+ versus Foxp3 cell subsets and of
peripheral Foxp3+ versus Foxp3 cell subsets showed limited
overlap (Hsieh et al., 2006). In agreement with these findings,
in mice expressing diabetogenic transgene-encoded abTCR
BDC2.5 specific for unidentified pancreatic self-antigen thymic
and periperal Foxp3+CD4+ cells expressed a similar repertoire
of endogenous TCRa chains, which were used in this study as
unique tags of individual T cell clones. This elegant approach,
made possible because generation of Foxp3+ cells in BDC2.5
TCR trangenic mice requires endogenous TCRa chain rearrange-
ment, revealed that TCRa chain utilization in thymic and periph-
eral Foxp3 non-Treg cells is distinct from Foxp3+ Treg cells
(Wong et al., 2007a). The most remarkable observation in this
study was that BDC2.5 TCR-expressing Treg and non-Treg cell
clones present in the pancreatic lymph nodes and pancreas,
and therefore exposed to chronic stimulation by self-antigen,
remained distinct with their endogenous TCRa chain usage
reflecting their thymic origin (Wong et al., 2007a). Together, these
results indicate that the majority of Treg cells present in the
periphery are of thymic origin and that iTreg cell generation has
specific prerequisites (Figure 1).
A requirement for a distinct TCR signal and specificity for iTreg
cell generation was revealed by the analysis of the TCR reper-
toire of Foxp3+ T cells generated upon transfer of purified
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to that of the progeny of divided cells that remained Foxp3 nega-
tive (Lathrop et al., 2008). The resulting TCR repertoires were
distinct and only partially overlapping in resemblance of TCR utili-
zation by Foxp3+ Treg cells and Foxp3 ‘‘non-Treg’’ CD4+ T cells
present in unmanipulated mice (Hsieh et al., 2004; Lathrop et al.,
2008). These results suggest that TCR of certain specificities
support iTreg cell differentiation. A nonmutually exclusive possi-
bility is that particular TCR specificities confer a poised state to
the Foxp3 locus and thus support more efficient Foxp3 induction.
First insights into similarities and differences between signal
requirements for thymic versus peripheral Foxp3 induction
came from in vitro studies. First, CTLA-4 is dispensable for tTreg
cell differentiation, but is required for TGF-b-mediated iTreg cell
generation in vitro (Zheng et al., 2006). Second, CD28 cross-link-
ing inhibits induction of Foxp3 in peripheral naive CD4 T cells
upon stimulation with TGF-b (Benson et al., 2007; Kim and
Rudensky, 2006), consistent with a requirement for suboptimal
TCR stimulation for iTreg cell generation. As a further mechanistic
insight into TCR signaling requirements for iTreg generation,
Merkenschlager and colleagues have demonstrated that early
withdrawal of TCR signaling through use of PI3K-mTOR signaling
pathway inhibitors after 18 hr of stimulation resulted in robust
induction of Foxp3 (Sauer et al., 2008). Consistent with these find-
ings, the Mathis and Benoist group showed that sustained Akt
activation inhibits stable Foxp3 induction in peripheral Foxp3
CD4+ T cells (Haxhinasto et al., 2008). A similar trend was
observed upon modulation of Akt during induction of Foxp3+ cells
in fetal thymic organ cultures, suggesting that in this regard iTreg
and tTreg cell induction are similar (Haxhinasto et al., 2008). Inter-
estingly, in contrast to the lack of generation of CARMA-1-defi-
cient Foxp3+ thymocytes, CARMA1-deficient peripheral CD4
T cells were able to induce Foxp3 in response to TGF-b, support-
ing the idea that mechanisms for differentiation of tTreg and iTreg
cell are distinct and that TCR-CD28-associated NF-kB signals
are dispensable for peripheral Foxp3 induction (Barnes et al.,
2009). However, distinct requirements for CARMA-1 for genera-
tion of tTreg versus iTreg cells might be a consequence of
iTreg cell generation in response to stronger TCR signals in the
absence of CARMA-1. In contrast, such signals may lead to death
of thymic precursors lacking CARMA-1.
TGF-b receptor signaling appears to be required for most, if not
all, of the induction of Foxp3 among peripheral naive CD4+ T cells
(Chen et al., 2003; Kretschmer et al., 2005; Selvaraj and Geiger,
2007; Zheng et al., 2004). IL-2 is also required for TGF-b-medi-
ated induction of Foxp3 in peripheral T cells in vitro (Davidson
et al., 2007; Horwitz et al., 2008). In addition to potential direct
STAT5-dependent regulation of the Foxp3 locus and promotion
of cell survival and division in the presence of high amounts of
TGF-b, IL-2 opposes differentiation of activated CD4+ T cells
into T helper 17 (Th17) cells (Laurence et al., 2007). The latter
differentiation pathway is favored when TCR and TGF-bR activa-
tion in naive CD4+ T cells coincides with IL-6R stimulation (Bettelli
et al., 2008). (A complex relationship between Th17 and iTreg
cells, representing alternative, yet related CD4+ T cell differentia-
tion fates is discussed in more detail by Zhou et al. [2009] in
this issue of Immunity). Another mechanism by which TGF-b
may regulate Treg cell differentiation is through the repression
of Gfi-1, a transcriptional repressor that inhibits the differentiationof both iTreg and Th17 cells upon activation of peripheral T cells
under Th2 conditions (Zhu et al., 2009).
The induction of Foxp3 upon chronic antigen exposure in vivo
also requires TGF-b receptor signaling and is inversely correlated
with cellular proliferation (Kretschmer et al., 2005). One possible
explanation for this phenomenon is provided by our recent find-
ings indicating that TGF-b cooperates with TCR signals to induce
Foxp3 in part by antagonizing cell-cycle-dependent recruitment
of maintenance DNA methyltransferase I (Dnmt1) to the Foxp3
locus resulting in its inactivation (Josefowicz et al., 2009, in this
issue of Immunity). Not mutually exclusive is the possibility that
signals, capable of inducing Foxp3, initiate chromatin remodeling
and establish a poised state of the Foxp3 locus and that conse-
quent robust proliferation accompanied by propagation of CpG
methylation by Dnmt1 may erase or prevent establishment of
this permissive state. Therefore, the cytostatic effects of inhibi-
tory signals emanating from CTLA-4 and TGF-bR may be partially
responsible for their effects on Foxp3 induction. Thus, TGF-b
appears to mediate differentiation of Treg cells through both
direct and indirect mechanisms, with Smad3 and NFAT binding
to Foxp3-CNS1 and a likely role for TGF-b signaling in survival
or fitness of tTreg cells or their precursors.
The sum of the data so far indicate that TCR-induced sustained
expression of high amounts of Foxp3 in peripheral T cells is influ-
enced by particular aspects of intracellular signaling pathways,
by kinetics of cellular proliferation, and by synergy with other
signals, such as TGF-b and IL-2. These features imply that iTreg
cell differentiation is limited to particular environments. The bulk
of experimental evidence points to gut-associated lymphoid
tissues (GALT) as a unique environment favoring iTreg cell gener-
ation. In this regard, CD103+ dendritic cells present in GALT or the
gut-draining mesenteric lymph nodes are capable of inducing
Foxp3 expression in peripheral naive CD4+ T cells through
production of TGF-b and retinoic acid (Figure 1; Annacker et al.,
2005; Benson et al., 2007; Coombes et al., 2007; Sun et al.,
2007). Although TGF-b acts directly, retinoic acid may predomi-
nantly enhance the induction of Foxp3 through curtailing produc-
tion of IL-4, IL-21, and IFN-g by bystander CD44hi effector
memory CD4+ T cells (Hill et al., 2008). However, retinoic acid still
exerts direct effects on iTreg cell differentiation (Elias et al., 2008;
Xiao et al., 2008). Interestingly, although retinoic acid augments
Foxp3 induction, it inhibits induction of IL-10, indicating that iTreg
cells and IL-10-producing Tr1 cells may represent competing and
alternative cell lineages (Maynard et al., 2009). The GALT and
mesenteric lymph nodes represent anatomical sites amenable
to the induction of Foxp3 in response to chronic antigen exposure
under tolerogenic conditions (Belkaid and Oldenhove, 2008; Cur-
otto de Lafaille et al., 2008; Hall et al., 2008; Kretschmer et al.,
2005, 2006). This notion is further supported by a distinct TCR
repertoire among Treg cells present in the mesenteric lymph no-
des compared to Treg cells from other lymphoid compartments
(Lathrop et al., 2008), likely reflecting the efficient generation of
iTreg cells induced by distinct gut-associated antigens such as
food and commensal microbiota-derived antigens.
Molecular Regulation of Foxp3 Gene Expression
One interesting characteristic of the Foxp3 gene is the weak
activity of the promoter alone, as observed in luciferase reporter
assays (Kim and Leonard, 2007; Tone et al., 2008). Therefore, itImmunity 30, May 22, 2009 ª2009 Elsevier Inc. 621
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other proximal regulatory elements. As discussed above, Foxp3-
CNS1, which contains binding sites for NFAT and TGF-b-acti-
vated Smad3, is likely important for the induction of Foxp3 in
peripheral naive CD4+ T cells. In addition to Smad3-dependent
activation of Foxp3-CNS1, other Foxp3 regulatory elements
are likely to impact the chromatin state, thereby promoting
accessibility of the Foxp3 locus and increasing probability of its
induction. Predictably, permissive chromatin modifications at
Foxp3-CNS1 and the Foxp3 promoter coincide with or directly
precede Foxp3 expression (Figure 2; Kim and Leonard, 2007;
Mantel et al., 2006; Sauer et al., 2008; Tone et al., 2008). Thus,
it will be important to identify additional regulatory elements,
transcription factors, and chromatin modifying and remodeling
complexes that act upon these elements to promote changes
in chromatin state allowing for induction of Foxp3 expression.
Given the central role Foxp3 plays in maintaining the Treg cell
transcriptional program and cellular phenotype, maintenance of
Foxp3 expression is central to Treg cell lineage stability. Although
in vitro manipulation of Treg cells such as cross-linking of the TNF
receptor superfamily member OX40 results in a loss of Foxp3
expression and suppressor activity in mature Treg cells (So and
Croft, 2007; Vu et al., 2007), adoptive transfers of Treg cells
into Treg cell-deficient mice demonstrated stability of Foxp3
expression (Komatsu et al., 2009). Additionally, cell-fate mapping
studies employing inducible Cre-mediated genetic marking of
Treg cells revealed heritable long-term maintenance of Foxp3
expression in the progeny of genetically tagged cells and, there-
fore, Treg cell lineage stability in unmanipulated mice (Rubtsov
and A.R., unpublished observations).
What are the mechanisms for stable maintenance of Foxp3
expression in mature Treg cells? Several recent studies have
pointed to CpG dinucleotide methylation at the Foxp3 locus—
at the promoter and at Foxp3-CNS2—as an important determi-
nant in regulation of Foxp3. Demethylation of CpG motifs at
the Foxp3 locus has been correlated with stable Foxp3 expres-
sion in ex vivo isolated human and mouse Treg cells. In contrast,
these elements remain methylated in iTreg cells generated
in vitro that do not stably express Foxp3 (Figure 2; Baron et al.,
2007; Floess et al., 2007; Polansky et al., 2008). One possible
consequence of continuous methylation of these CpG-contain-
ing elements in iTreg cells is that transcription factors like the
methyl-sensitive CREB fail to bind to Foxp3-CNS2. It is implicit
in this line of reasoning that demethylation of Foxp3-CNS2 facil-
itates binding of transcription factors that mediate stable heri-
table maintenance of Foxp3 expression.
It is noteworthy that there are differences in Foxp3 expression
upon activation of conventional T cells in humans and mice (Zie-
gler, 2006). Although stable high expression of Foxp3 is restricted
to Treg cells in both species, Foxp3 is induced after stimulation of
human T cells (Allan et al., 2005; Gavin et al., 2006; Morgan et al.,
2005; Walker et al., 2003; Wang et al., 2007). This relatively low
Foxp3 expression in activated human T cells is dependent
upon TGF-bproduced by activated T cells or present in the serum
and it does not result in acquisition of Treg cell phenotype and
suppressor function (Gavin et al., 2006; Wang et al., 2007).
Furthermore, induction of Foxp3 expression in conventional
human T cells in the presence of high amounts of TGF-b fails to
confer suppressor function (Shevach et al., 2008; Tran et al.,622 Immunity 30, May 22, 2009 ª2009 Elsevier Inc.2007). It is likely that transient, low expression of Foxp3 upon
activation of conventional human T cells and unstable expression
of Foxp3 in iTreg cells generated in vitro is the result of a lack of
engagement of the highly methylated Foxp3-CNS2. Consistent
with this idea, pharmacologic inhibition, knockdown, or ablation
of the Dnmt1 gene and resultant CpG motif demethylation
substantially increases both induction and stability of Foxp3
expression (Kim and Leonard, 2007; Polansky et al., 2008; Jose-
fowicz et al., 2009). The mechanisms responsible for establishing
the appropriate chromatin characteristics, demethylation of
Foxp3-CNS2, and the propagation of these states for heritable
maintenance of Foxp3 expression in dividing Treg cells are
largely unknown. However, Foxp3 protein itself appears to be
required for the heritable maintenance of Foxp3 expression, but
does not augment the expression level of Foxp3 on a per cell
basis, suggesting existence of a feed-forward regulatory loop
(Figure 2; Gavin et al., 2007). Based on these observations, it is
possible that Foxp3, a lineage-specifying transcription factor of
Treg cells, promotes its own heritable maintenance in the
progeny of dividing Treg cells representing a simple mechanism
of Treg cell lineage stability.
Further advances in mechanistic understanding of known and
elucidation of unknown signals that determine the sustained
induction of Foxp3 during thymic and peripheral Treg cell differ-
entiation will facilitate development of novel approaches to the
therapeutic manipulation of regulatory T cells.
ACKNOWLEDGMENTS
We thank the members of our laboratory for stimulating discussions and M.
Busslinger for sharing unpublished data. This work was supported by
AI061816 grant from the National Institutes of Health (A.Y.R.). A.Y.R. is an
investigator of the Howard Hughes Medical Insitute.
REFERENCES
Allan, S.E., Passerini, L., Bacchetta, R., Crellin, N., Dai, M., Orban, P.C.,
Ziegler, S.F., Roncarolo, M.G., and Levings, M.K. (2005). The role of
2 FOXP3 isoforms in the generation of human CD4+ Tregs. J. Clin. Invest.
115, 3276–3284.
Annacker, O., Coombes, J.L., Malmstrom, V., Uhlig, H.H., Bourne, T., Johans-
son-Lindbom, B., Agace, W.W., Parker, C.M., and Powrie, F. (2005). Essential
role for CD103 in the T cell-mediated regulation of experimental colitis. J. Exp.
Med. 202, 1051–1061.
Apostolou, I., Sarukhan, A., Klein, L., and von Boehmer, H. (2002). Origin of
regulatory T cells with known specificity for antigen. Nat. Immunol. 3, 756–763.
Asano, M., Toda, M., Sakaguchi, N., and Sakaguchi, S. (1996). Autoimmune
disease as a consequence of developmental abnormality of a T cell subpopu-
lation. J. Exp. Med. 184, 387–396.
Azzam, H.S., DeJarnette, J.B., Huang, K., Emmons, R., Park, C.S., Sommers,
C.L., El-Khoury, D., Shores, E.W., and Love, P.E. (2001). Fine tuning of TCR
signaling by CD5. J. Immunol. 166, 5464–5472.
Barnes, M.J., Krebs, P., Harris, N., Eidenschenk, C., Gonzalez-Quintial, R.,
Arnold, C.N., Crozat, K., Sovath, S., Moresco, E.M., Theofilopoulos, A.N.,
et al. (2009). Commitment to the regulatory T cell lineage requires CARMA1
in the thymus but not in the periphery. PLoS Biol. 7, e51.
Baron, U., Floess, S., Wieczorek, G., Baumann, K., Grutzkau, A., Dong, J.,
Thiel, A., Boeld, T.J., Hoffmann, P., Edinger, M., et al. (2007). DNA demethyla-
tion in the human FOXP3 locus discriminates regulatory T cells from activated
FOXP3(+) conventional T cells. Eur. J. Immunol. 37, 2378–2389.
Bautista, J.L., Lio, C.W., Lathrop, S.K., Forbush, K., Liang, Y., Luo, J.,
Rudensky, A.Y., and Hsieh, C.S. (2009). Intraclonal competition limits the
Immunity
Reviewfate determination of regulatory T cells in the thymus. Nat. Immunol., in press.
Published online May 10, 2009. 10.1038/ni.1739.
Belkaid, Y., and Oldenhove, G. (2008). Tuning microenvironments: induction of
regulatory T cells by dendritic cells. Immunity 29, 362–371.
Bennett, C.L., Christie, J., Ramsdell, F., Brunkow, M.E., Ferguson, P.J., White-
sell, L., Kelly, T.E., Saulsbury, F.T., Chance, P.F., and Ochs, H.D. (2001). The
immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome
(IPEX) is caused by mutations of FOXP3. Nat. Genet. 27, 20–21.
Benson, M.J., Pino-Lagos, K., Rosemblatt, M., and Noelle, R.J. (2007). All-
trans retinoic acid mediates enhanced T reg cell growth, differentiation, and
gut homing in the face of high levels of co-stimulation. J. Exp. Med. 204,
1765–1774.
Bettelli, E., Korn, T., Oukka, M., and Kuchroo, V.K. (2008). Induction and
effector functions of T(H)17 cells. Nature 453, 1051–1057.
Bonomo, A., Kehn, P.J., Payer, E., Rizzo, L., Cheever, A.W., and Shevach,
E.M. (1995). Pathogenesis of post-thymectomy autoimmunity. Role of synge-
neic MLR-reactive T cells. J. Immunol. 154, 6602–6611.
Brunkow, M.E., Jeffery, E.W., Hjerrild, K.A., Paeper, B., Clark, L.B., Yasayko,
S.A., Wilkinson, J.E., Galas, D., Ziegler, S.F., and Ramsdell, F. (2001). Disrup-
tion of a new forkhead/winged-helix protein, scurfin, results in the fatal
lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27, 68–73.
Burchill, M.A., Goetz, C.A., Prlic, M., O’Neil, J.J., Harmon, I.R., Bensinger, S.J.,
Turka, L.A., Brennan, P., Jameson, S.C., and Farrar, M.A. (2003). Distinct
effects of STAT5 activation on CD4+ and CD8+ T cell homeostasis: Develop-
ment of CD4+CD25+ regulatory T cells versus CD8+ memory T cells. J. Immu-
nol. 171, 5853–5864.
Burchill, M.A., Yang, J., Vang, K.B., and Farrar, M.A. (2007a). Interleukin-2
receptor signaling in regulatory T cell development and homeostasis. Immu-
nol. Lett. 114, 1–8.
Burchill, M.A., Yang, J., Vogtenhuber, C., Blazar, B.R., and Farrar, M.A.
(2007b). IL-2 receptor beta-dependent STAT5 activation is required for the
development of Foxp3+ regulatory T cells. J. Immunol. 178, 280–290.
Burchill, M.A., Yang, J., Vang, K.B., Moon, J.J., Chu, H.H., Lio, C.W., Vegoe,
A.L., Hsieh, C.S., Jenkins, M.K., and Farrar, M.A. (2008). Linked T cell receptor
and cytokine signaling govern the development of the regulatory T cell reper-
toire. Immunity 28, 112–121.
Carter, J.D., Calabrese, G.M., Naganuma, M., and Lorenz, U. (2005). Defi-
ciency of the Src homology region 2 domain-containing phosphatase 1
(SHP-1) causes enrichment of CD4+CD25+ regulatory T cells. J. Immunol.
174, 6627–6638.
Chatila, T.A., Blaeser, F., Ho, N., Lederman, H.M., Voulgaropoulos, C., Helms,
C., and Bowcock, A.M. (2000). JM2, encoding a fork head-related protein, is
mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin.
Invest. 106, R75–R81.
Chen, W., Jin, W., Hardegen, N., Lei, K.J., Li, L., Marinos, N., McGrady, G., and
Wahl, S.M. (2003). Conversion of peripheral CD4+CD25- naive T cells to
CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor
Foxp3. J. Exp. Med. 198, 1875–1886.
Chen, Z., Benoist, C., and Mathis, D. (2005). How defects in central tolerance
impinge on a deficiency in regulatory T cells. Proc. Natl. Acad. Sci. USA 102,
14735–14740.
Coombes, J.L., Siddiqui, K.R., Arancibia-Carcamo, C.V., Hall, J., Sun, C.M.,
Belkaid, Y., and Powrie, F. (2007). A functionally specialized population of
mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and
retinoic acid-dependent mechanism. J. Exp. Med. 204, 1757–1764.
Curotto de Lafaille, M.A., Kutchukhidze, N., Shen, S., Ding, Y., Yee, H., and
Lafaille, J.J. (2008). Adaptive Foxp3+ regulatory T cell-dependent and -inde-
pendent control of allergic inflammation. Immunity 29, 114–126.
Curotto de Lafaille, M.A., and Lafaille, J.J. (2009). Natural and adaptive Foxp3+
regulatory t cells: More of the same or a division of labor. Immunity 30, this
issue, 626–635.
Davidson, T.S., DiPaolo, R.J., Andersson, J., and Shevach, E.M. (2007).
Cutting edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T
regulatory cells. J. Immunol. 178, 4022–4026.Ehrlich, P. (1906). Collected Studies on Immunity (New York: Wiley).
Elias, K.M., Laurence, A., Davidson, T.S., Stephens, G., Kanno, Y., Shevach,
E.M., and O’Shea, J.J. (2008). Retinoic acid inhibits Th17 polarization and
enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling
pathway. Blood 111, 1013–1020.
Floess, S., Freyer, J., Siewert, C., Baron, U., Olek, S., Polansky, J., Schlawe,
K., Chang, H.D., Bopp, T., Schmitt, E., et al. (2007). Epigenetic control of the
foxp3 locus in regulatory T cells. PLoS Biol. 5, e38.
Fontenot, J.D., Gavin, M.A., and Rudensky, A.Y. (2003). Foxp3 programs the
development and function of CD4+CD25+ regulatory T cells. Nat. Immunol.
4, 330–336.
Fontenot, J.D., Dooley, J.L., Farr, A.G., and Rudensky, A.Y. (2005a). Develop-
mental regulation of Foxp3 expression during ontogeny. J. Exp. Med. 202,
901–906.
Fontenot, J.D., Rasmussen, J.P., Gavin, M.A., and Rudensky, A.Y. (2005b). A
function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol.
6, 1142–1151.
Fontenot, J.D., Rasmussen, J.P., Williams, L.M., Dooley, J.L., Farr, A.G., and
Rudensky, A.Y. (2005c). Regulatory T cell lineage specification by the forkhead
transcription factor foxp3. Immunity 22, 329–341.
Gavin, M.A., and Bevan, M.J. (1995). Increased peptide promiscuity provides
a rationale for the lack of N regions in the neonatal T cell repertoire. Immunity 3,
793–800.
Gavin, M.A., Torgerson, T.R., Houston, E., DeRoos, P., Ho, W.Y., Stray-Peder-
sen, A., Ocheltree, E.L., Greenberg, P.D., Ochs, H.D., and Rudensky, A.Y.
(2006). Single-cell analysis of normal and FOXP3-mutant human T cells:
FOXP3 expression without regulatory T cell development. Proc. Natl. Acad.
Sci. USA 103, 6659–6664.
Gavin, M.A., Rasmussen, J.P., Fontenot, J.D., Vasta, V., Manganiello, V.C.,
Beavo, J.A., and Rudensky, A.Y. (2007). Foxp3-dependent programme of
regulatory T-cell differentiation. Nature 445, 771–775.
Germain, R.N. (2002). T-cell development and the CD4–CD8 lineage decision.
Nat. Rev. Immunol. 2, 309–322.
Gupta, S., Manicassamy, S., Vasu, C., Kumar, A., Shang, W., and Sun, Z.
(2008). Differential requirement of PKC-theta in the development and function
of natural regulatory T cells. Mol. Immunol. 46, 213–224.
Hall, J.A., Bouladoux, N., Sun, C.M., Wohlfert, E.A., Blank, R.B., Zhu, Q., Grigg,
M.E., Berzofsky, J.A., and Belkaid, Y. (2008). Commensal DNA limits regula-
tory T cell conversion and is a natural adjuvant of intestinal immune responses.
Immunity 29, 637–649.
Haxhinasto, S., Mathis, D., and Benoist, C. (2008). The AKT-mTOR axis regu-
lates de novo differentiation of CD4+Foxp3+ cells. J. Exp. Med. 205, 565–574.
Hill, J.A., Hall, J.A., Sun, C.M., Cai, Q., Ghyselinck, N., Chambon, P., Belkaid,
Y., Mathis, D., and Benoist, C. (2008). Retinoic acid enhances Foxp3 induction
indirectly by relieving inhibition from CD4+CD44hi Cells. Immunity 29, 758–
770.
Hori, S., Nomura, T., and Sakaguchi, S. (2003). Control of regulatory T cell
development by the transcription factor Foxp3. Science 299, 1057–1061.
Horwitz, D.A., Zheng, S.G., Wang, J., and Gray, J.D. (2008). Critical role of IL-2
and TGF-beta in generation, function and stabilization of Foxp3+CD4+ Treg.
Eur. J. Immunol. 38, 912–915.
Hsieh, C.S., Liang, Y., Tyznik, A.J., Self, S.G., Liggitt, D., and Rudensky, A.Y.
(2004). Recognition of the peripheral self by naturally arising CD25+ CD4+
T cell receptors. Immunity 21, 267–277.
Hsieh, C.S., Zheng, Y., Liang, Y., Fontenot, J.D., and Rudensky, A.Y. (2006).
An intersection between the self-reactive regulatory and nonregulatory T cell
receptor repertoires. Nat. Immunol. 7, 401–410.
Jordan, M.S., Boesteanu, A., Reed, A.J., Petrone, A.L., Holenbeck, A.E.,
Lerman, M.A., Naji, A., and Caton, A.J. (2001). Thymic selection of CD4+
CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol.
2, 301–306.Immunity 30, May 22, 2009 ª2009 Elsevier Inc. 623
Immunity
ReviewJosefowicz, S.Z., Wilson, C.B., and Rudensky, A.Y. (2009). Cutting edge: TCR
stimulation is sufficient for induction of Foxp3 expression in the absence of
DNA methyltransferase 1. J. Immunol. 182, in press.
Kawahata, K., Misaki, Y., Yamauchi, M., Tsunekawa, S., Setoguchi, K., Miya-
zaki, J., and Yamamoto, K. (2002). Generation of CD4(+)CD25(+) regulatory
T cells from autoreactive T cells simultaneously with their negative selection
in the thymus and from nonautoreactive T cells by endogenous TCR expres-
sion. J. Immunol. 168, 4399–4405.
Khattri, R., Cox, T., Yasayko, S.A., and Ramsdell, F. (2003). An essential role
for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4, 337–342.
Kim, H.P., and Leonard, W.J. (2007). CREB/ATF-dependent T cell receptor-
induced FoxP3 gene expression: A role for DNA methylation. J. Exp. Med.
204, 1543–1551.
Kim, J.M., and Rudensky, A. (2006). The role of the transcription factor Foxp3
in the development of regulatory T cells. Immunol. Rev. 212, 86–98.
Komatsu, N., Mariotti-Ferrandiz, M.E., Wang, Y., Malissen, B., Waldmann, H.,
and Hori, S. (2009). Heterogeneity of natural Foxp3+ T cells: A committed regu-
latory T-cell lineage and an uncommitted minor population retaining plasticity.
Proc. Natl. Acad. Sci. USA 106, 1903–1908.
Kretschmer, K., Apostolou, I., Hawiger, D., Khazaie, K., Nussenzweig, M.C.,
and von Boehmer, H. (2005). Inducing and expanding regulatory T cell popu-
lations by foreign antigen. Nat. Immunol. 6, 1219–1227.
Kretschmer, K., Heng, T.S., and von Boehmer, H. (2006). De novo production
of antigen-specific suppressor cells in vivo. Nat. Protocols 1, 653–661.
Lathrop, S.K., Santacruz, N.A., Pham, D., Luo, J., and Hsieh, C.S. (2008).
Antigen-specific peripheral shaping of the natural regulatory T cell population.
J. Exp. Med. 205, 3105–3117.
Laurence, A., Tato, C.M., Davidson, T.S., Kanno, Y., Chen, Z., Yao, Z., Blank,
R.B., Meylan, F., Siegel, R., Hennighausen, L., et al. (2007). Interleukin-2
signaling via STAT5 constrains T helper 17 cell generation. Immunity 26,
371–381.
Li, M.O., Sanjabi, S., and Flavell, R.A. (2006). Transforming growth factor-beta
controls development, homeostasis, and tolerance of T cells by regulatory
T cell-dependent and -independent mechanisms. Immunity 25, 455–471.
Lin, W., Haribhai, D., Relland, L.M., Truong, N., Carlson, M.R., Williams, C.B.,
and Chatila, T.A. (2007). Regulatory T cell development in the absence of
functional Foxp3. Nat. Immunol. 8, 359–368.
Lio, C.W., and Hsieh, C.S. (2008). A two-step process for thymic regulatory
T cell development. Immunity 28, 100–111.
Liu, Y., Zhang, P., Li, J., Kulkarni, A.B., Perruche, S., and Chen, W. (2008). A
critical function for TGF-beta signaling in the development of natural
CD4+CD25+Foxp3+ regulatory T cells. Nat. Immunol. 9, 632–640.
Malek, T.R. (2008). The biology of interleukin-2. Annu. Rev. Immunol. 26,
453–479.
Mantel, P.Y., Ouaked, N., Ruckert, B., Karagiannidis, C., Welz, R., Blaser, K.,
and Schmidt-Weber, C.B. (2006). Molecular mechanisms underlying FOXP3
induction in human T cells. J. Immunol. 176, 3593–3602.
Marie, J.C., Letterio, J.J., Gavin, M., and Rudensky, A.Y. (2005). TGF-beta1
maintains suppressor function and Foxp3 expression in CD4+CD25+ regula-
tory T cells. J. Exp. Med. 201, 1061–1067.
Marie, J.C., Liggitt, D., and Rudensky, A.Y. (2006). Cellular mechanisms of fatal
early-onset autoimmunity in mice with the T cell-specific targeting of trans-
forming growth factor-beta receptor. Immunity 25, 441–454.
Maynard, C.L., Hatton, R.D., Helms, W.S., Oliver, J.R., Stephensen, C.B., and
Weaver, C.T. (2009). Contrasting roles for all-trans retinoic acid in TGF-beta-
mediated induction of Foxp3 and Il10 genes in developing regulatory T cells.
J. Exp. Med. 206, 343–357.
Medoff, B.D., Sandall, B.P., Landry, A., Nagahama, K., Mizoguchi, A., Luster,
A.D., and Xavier, R.J. (2009). Differential requirement for CARMA1 in agonist-
selected T-cell development. Eur. J. Immunol. 39, 78–84.
Molinero, L.L., Yang, J., Gajewski, T., Abraham, C., Farrar, M.A., and Alegre,
M. (2009). CARMA1 controls an early checkpoint in the thymic development
of FoxP3+ regulatory T cells. J. Immunol. 182, in press.624 Immunity 30, May 22, 2009 ª2009 Elsevier Inc.Morgan, M.E., van Bilsen, J.H., Bakker, A.M., Heemskerk, B., Schilham, M.W.,
Hartgers, F.C., Elferink, B.G., van der Zanden, L., de Vries, R.R., Huizinga,
T.W., et al. (2005). Expression of FOXP3 mRNA is not confined to
CD4+CD25+ T regulatory cells in humans. Hum. Immunol. 66, 13–20.
Nishizuka, Y., and Sakakura, T. (1969). Thymus and reproduction: sex-linked
dysgenesia of the gonad after neonatal thymectomy in mice. Science 166,
753–755.
Ohki, H., Martin, C., Corbel, C., Coltey, M., and Le Douarin, N.M. (1987). Toler-
ance induced by thymic epithelial grafts in birds. Science 237, 1032–1035.
Olivares-Villagomez, D., Wang, Y., and Lafaille, J.J. (1998). Regulatory CD4(+)
T cells expressing endogenous T cell receptor chains protect myelin basic
protein-specific transgenic mice from spontaneous autoimmune encephalo-
myelitis. J. Exp. Med. 188, 1883–1894.
Pacholczyk, R., and Kern, J. (2008). The T-cell receptor repertoire of regulatory
T cells. Immunology 125, 450–458.
Pacholczyk, R., Ignatowicz, H., Kraj, P., and Ignatowicz, L. (2006). Origin and
T cell receptor diversity of Foxp3+CD4+CD25+ T cells. Immunity 25, 249–259.
Polansky, J.K., Kretschmer, K., Freyer, J., Floess, S., Garbe, A., Baron, U.,
Olek, S., Hamann, A., von Boehmer, H., and Huehn, J. (2008). DNA methylation
controls Foxp3 gene expression. Eur. J. Immunol. 38, 1654–1663.
Sakaguchi, S., Takahashi, T., and Nishizuka, Y. (1982). Study on cellular events
in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1
effector cells for oocytes damage after adoptive transfer. J. Exp. Med. 156,
1565–1576.
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., and Toda, M. (1995). Immu-
nologic self-tolerance maintained by activated T cells expressing IL-2 receptor
alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance
causes various autoimmune diseases. J. Immunol. 155, 1151–1164.
Salomon, B., Lenschow, D.J., Rhee, L., Ashourian, N., Singh, B., Sharpe, A.,
and Bluestone, J.A. (2000). B7/CD28 costimulation is essential for the homeo-
stasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune
diabetes. Immunity 12, 431–440.
Sauer, S., Bruno, L., Hertweck, A., Finlay, D., Leleu, M., Spivakov, M., Knight,
Z.A., Cobb, B.S., Cantrell, D., O’Connor, E., et al. (2008). T cell receptor
signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl.
Acad. Sci. USA 105, 7797–7802.
Schmidt-Supprian, M., Tian, J., Grant, E.P., Pasparakis, M., Maehr, R., Ovaa,
H., Ploegh, H.L., Coyle, A.J., and Rajewsky, K. (2004). Differential dependence
of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to
NF-kappaB activation. Proc. Natl. Acad. Sci. USA 101, 4566–4571.
Selvaraj, R.K., and Geiger, T.L. (2007). A kinetic and dynamic analysis of Foxp3
induced in T cells by TGF-beta. J. Immunol. 179, 1390–1401.
Shevach, E.M., Tran, D.Q., Davidson, T.S., and Andersson, J. (2008). The
critical contribution of TGF-beta to the induction of Foxp3 expression and
regulatory T cell function. Eur. J. Immunol. 38, 915–917.
Shevach, E.M. (2009). Mechanisms of Foxp3+ T regulatory cell-mediated
suppression. Immunity 30, this issue, 636–645.
Singer, A., Adoro, S., and Park, J.H. (2008). Lineage fate and intense debate:
Myths, models and mechanisms of CD4- versus CD8-lineage choice. Nat.
Rev. Immunol. 8, 788–801.
So, T., and Croft, M. (2007). Cutting edge: OX40 inhibits TGF-beta- and
antigen-driven conversion of naive CD4 T cells into CD25+Foxp3+ T cells.
J. Immunol. 179, 1427–1430.
Sriskantharajah, S., Belich, M.P., Papoutsopoulou, S., Janzen, J., Tybulewicz,
V., Seddon, B., and Ley, S.C. (2009). Proteolysis of NF-kappaB1 p105 is
essential for T cell antigen receptor-induced proliferation. Nat. Immunol. 10,
38–47.
Sun, C.M., Hall, J.A., Blank, R.B., Bouladoux, N., Oukka, M., Mora, J.R., and
Belkaid, Y. (2007). Small intestine lamina propria dendritic cells promote de
novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204,
1775–1785.
Tai, X., Cowan, M., Feigenbaum, L., and Singer, A. (2005). CD28 costimulation
of developing thymocytes induces Foxp3 expression and regulatory T cell
differentiation independently of interleukin 2. Nat. Immunol. 6, 152–162.
Immunity
ReviewTone, Y., Furuuchi, K., Kojima, Y., Tykocinski, M.L., Greene, M.I., and Tone, M.
(2008). Smad3 and NFAT cooperate to induce Foxp3 expression through its
enhancer. Nat. Immunol. 9, 194–202.
Tran, D.Q., Ramsey, H., and Shevach, E.M. (2007). Induction of FOXP3
expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation
is transforming growth factor-beta dependent but does not confer a regulatory
phenotype. Blood 110, 2983–2990.
van Santen, H.M., Benoist, C., and Mathis, D. (2004). Number of T reg cells that
differentiate does not increase upon encounter of agonist ligand on thymic
epithelial cells. J. Exp. Med. 200, 1221–1230.
Vang, K.B., Yang, J., Mahmud, S.A., Burchill, M.A., Vegoe, A.L., and Farrar,
M.A. (2008). IL-2, -7, and -15, but not thymic stromal lymphopoeitin, redun-
dantly govern CD4+Foxp3+ regulatory T cell development. J. Immunol. 181,
3285–3290.
Vu, M.D., Xiao, X., Gao, W., Degauque, N., Chen, M., Kroemer, A., Killeen, N.,
Ishii, N., and Chang Li, X. (2007). OX40 costimulation turns off Foxp3+ Tregs.
Blood 110, 2501–2510.
Walker, L.S., Chodos, A., Eggena, M., Dooms, H., and Abbas, A.K. (2003).
Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo.
J. Exp. Med. 198, 249–258.
Wan, Y.Y., and Flavell, R.A. (2007). Regulatory T-cell functions are subverted
and converted owing to attenuated Foxp3 expression. Nature 445, 766–770.
Wang, J., Ioan-Facsinay, A., van der Voort, E.I., Huizinga, T.W., and Toes, R.E.
(2007). Transient expression of FOXP3 in human activated nonregulatory
CD4+ T cells. Eur. J. Immunol. 37, 129–138.
Wildin, R.S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.L., Buist, N.,
Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001). X-linked
neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the
human equivalent of mouse scurfy. Nat. Genet. 27, 18–20.
Williams, L.M., and Rudensky, A.Y. (2007). Maintenance of the Foxp3-depen-
dent developmental program in mature regulatory T cells requires continued
expression of Foxp3. Nat. Immunol. 8, 277–284.Wong, P., Barton, G.M., Forbush, K.A., and Rudensky, A.Y. (2001). Dynamic
tuning of T cell reactivity by self-peptide-major histocompatibility complex
ligands. J. Exp. Med. 193, 1179–1187.
Wong, J., Mathis, D., and Benoist, C. (2007a). TCR-based lineage tracing: no
evidence for conversion of conventional into regulatory T cells in response to
a natural self-antigen in pancreatic islets. J. Exp. Med. 204, 2039–2045.
Wong, J., Obst, R., Correia-Neves, M., Losyev, G., Mathis, D., and Benoist, C.
(2007b). Adaptation of TCR repertoires to self-peptides in regulatory and
nonregulatory CD4+ T cells. J. Immunol. 178, 7032–7041.
Xiao, S., Jin, H., Korn, T., Liu, S.M., Oukka, M., Lim, B., and Kuchroo, V.K.
(2008). Retinoic acid increases Foxp3+ regulatory T cells and inhibits develop-
ment of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and
inhibiting IL-6 and IL-23 receptor expression. J. Immunol. 181, 2277–2284.
Yao, Z., Kanno, Y., Kerenyi, M., Stephens, G., Durant, L., Watford, W.T.,
Laurence, A., Robinson, G.W., Shevach, E.M., Moriggl, R., et al. (2007). Nonre-
dundant roles for Stat5a/b in directly regulating Foxp3. Blood 109, 4368–4375.
Zheng, S.G., Wang, J.H., Gray, J.D., Soucier, H., and Horwitz, D.A. (2004).
Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop
suppressive activity: the role of IL-2, TGF-beta, and IL-10. J. Immunol. 172,
5213–5221.
Zheng, S.G., Wang, J.H., Stohl, W., Kim, K.S., Gray, J.D., and Horwitz, D.A.
(2006). TGF-beta requires CTLA-4 early after T cell activation to induce
FoxP3 and generate adaptive CD4+CD25+ regulatory cells. J. Immunol.
176, 3321–3329.
Zhu, J., Davidson, T.S., Wei, G., Jankovic, D., Cui, K., Schones, D.E., Guo, L.,
Zhao, K., Shevach, E.M., and Paul, W.E. (2009). Down-regulation of Gfi-1
expression by TGF-{beta} is important for differentiation of Th17 and
CD103+ inducible regulatory T cells. J. Exp. Med. 206, 329–341.
Ziegler, S.F. (2006). FOXP3: of mice and men. Annu. Rev. Immunol. 24,
209–226.
Zhou, L., Chong, M.M.W., and Littman, D.R. (2009). Plasticity of CD4+ T cell
lineage differentiation. Immunity 30, this issue, 646–655.Immunity 30, May 22, 2009 ª2009 Elsevier Inc. 625
